Búsqueda | Portal de Búsqueda de la BVS España

1.

Neuroimmune interplay during type 2 inflammation: Symptoms, mechanisms, and therapeutic targets in atopic diseases.

Kim, Brian; Rothenberg, Marc E; Sun, Xin; Bachert, Claus; Artis, David; Zaheer, Raza; Deniz, Yamo; Rowe, Paul; Cyr, Sonya.

J Allergy Clin Immunol; 153(4): 879-893, 2024 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-37634890

2.

A case series of live attenuated vaccine administration in dupilumab-treated children with atopic dermatitis.

Siegfried, Elaine C; Wine Lee, Lara; Spergel, Jonathan M; Prescilla, Randy; Uppal, Sumeet; Coleman, Anna; Bansal, Ashish; Cyr, Sonya L; Shumel, Brad.

Pediatr Dermatol; 41(2): 204-209, 2024.

Artículo en Inglés | MEDLINE | ID: mdl-38308453

3.

Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.

Paller, Amy S; Beck, Lisa A; Blauvelt, Andrew; Siegfried, Elaine C; Cork, Michael J; Wollenberg, Andreas; Chen, Zhen; Khokhar, Faisal A; Vakil, Jignesh; Zhang, Annie; Bansal, Ashish; Cyr, Sonya L.

Pediatr Dermatol; 39(2): 187-196, 2022 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-35083774

4.

Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis.

Paller, Amy S; Siegfried, Elaine C; Cork, Michael J; Arkwright, Peter D; Eichenfield, Lawrence F; Ramien, Michele; Khokhar, Faisal A; Chen, Zhen; Zhang, Annie; Cyr, Sonya L.

Paediatr Drugs; 26(2): 163-173, 2024 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-38267692

5.

No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with Dupilumab.

Blauvelt, Andrew; Wollenberg, Andreas; Eichenfield, Lawrence F; Zhang, Haixin; Sierka, Debra; Khokhar, Faisal A; Vakil, Jignesh; Shabbir, Arsalan; Marco, Ainara Rodríguez; Cyr, Sonya L.

Adv Ther; 40(1): 367-380, 2023 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-36318387

6.

Dupilumab Provides Clinically Meaningful Responses in Children Aged 6-11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial.

Siegfried, Elaine C; Cork, Michael J; Katoh, Norito; Zhang, Haixin; Chuang, Chien-Chia; Thomas, Ryan B; Rossi, Ana B; Cyr, Sonya L; Zhang, Annie.

Am J Clin Dermatol; 24(5): 787-798, 2023 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-37300760

7.

Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis.

Haddad, El-Bdaoui; Cyr, Sonya L; Arima, Kazuhiko; McDonald, Robert A; Levit, Noah A; Nestle, Frank O.

Dermatol Ther (Heidelb); 12(7): 1501-1533, 2022 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-35596901

8.

Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials.

Griffiths, Christopher; de Bruin-Weller, Marjolein; Deleuran, Mette; Fargnoli, Maria Concetta; Staumont-Sallé, Delphine; Hong, Chih-Ho; Sánchez-Carazo, Jose; Foley, Peter; Seo, Seong Jun; Msihid, Jérôme; Chen, Zhen; Cyr, Sonya L; Rossi, Ana B.

Dermatol Ther (Heidelb); 11(4): 1357-1372, 2021 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-34142350

9.

Hospital Cost of Staphylococcal Infection after Cardiothoracic or Orthopedic Operations in France: A Retrospective Database Analysis.

Schmidt, Aurélie; Bénard, Stève; Cyr, Sonya.

Surg Infect (Larchmt); 16(4): 428-35, 2015 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-26207403

10.

Mucosal immunology - 11th International Congress.

Cyr, Sonya.

IDrugs; 5(8): 753-6, 2002 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-14686363

11.

Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.

Huang, Yan; Cyr, Sonya L; Burt, David S; Anderson, Robert.

J Clin Virol; 44(4): 287-91, 2009 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-19233722

12.

TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model.

Cyr, Sonya L; Angers, Isabelle; Guillot, Loic; Stoica-Popescu, Ioana; Lussier, Michèle; Qureshi, Salman; Burt, David S; Ward, Brian J.

Vaccine; 27(3): 421-30, 2009 Jan 14.

Artículo en Inglés | MEDLINE | ID: mdl-19013492

13.

C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine.

Cyr, Sonya L; Jones, Taff; Stoica-Popescu, Ioana; Burt, David; Ward, Brian J.

Vaccine; 25(16): 3228-32, 2007 Apr 20.

Artículo en Inglés | MEDLINE | ID: mdl-17374422

14.

Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.

Cyr, Sonya L; Jones, Taff; Stoica-Popescu, Ioana; Brewer, Angela; Chabot, Sophie; Lussier, Michelle; Burt, David; Ward, Brian J.

Vaccine; 25(29): 5378-89, 2007 Jul 20.

Artículo en Inglés | MEDLINE | ID: mdl-17561317

15.

TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces.

Chabot, Sophie M; Chernin, Tyler S; Shawi, May; Wagner, Jessica; Farrant, Stephanie; Burt, David S; Cyr, Sonya; Neutra, Marian R.

Vaccine; 25(29): 5348-58, 2007 Jul 20.

Artículo en Inglés | MEDLINE | ID: mdl-17582662

16.

Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection.

Jones, Taff; Adamovicz, Jeffrey J; Cyr, Sonya L; Bolt, Chris R; Bellerose, Nathalie; Pitt, Louise M; Lowell, George H; Burt, David S.

Vaccine; 24(10): 1625-32, 2006 Mar 06.

Artículo en Inglés | MEDLINE | ID: mdl-16243411

17.

A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice.

Chabot, Sophie; Brewer, Angela; Lowell, George; Plante, Martin; Cyr, Sonya; Burt, David S; Ward, Brian J.

Vaccine; 23(11): 1374-83, 2005 Feb 03.

Artículo en Inglés | MEDLINE | ID: mdl-15661386

18.

Protollin: a novel adjuvant for intranasal vaccines.

Jones, Taff; Cyr, Sonya; Allard, Francine; Bellerose, Nathalie; Lowell, George H; Burt, David S.

Vaccine; 22(27-28): 3691-7, 2004 Sep 09.

Artículo en Inglés | MEDLINE | ID: mdl-15315848

19.

A nasal Proteosome influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunity.

Jones, Taff; Allard, Francine; Cyr, Sonya L; Tran, Steven P; Plante, Martin; Gauthier, Joelle; Bellerose, Nathalie; Lowell, George H; Burt, David S.

Vaccine; 21(25-26): 3706-12, 2003 Sep 08.

Artículo en Inglés | MEDLINE | ID: mdl-12922101

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: